Repaglinide

Drugs used in diabetes | Endocrine System

Items (National)
40.4K
NHS Cost
£226.3K
Practices
1,672
Avg per Practice
24

Overview

Repaglinide is prescribed by 1,672 GP practices across England. In the last 12 months, 40,430 items were prescribed at a total cost of £226,254 to the NHS. It is classified under BNF Chapter Endocrine System, Section Drugs used in diabetes.

Monthly Prescribing Trend

No monthly data available.

Prescribing by Area

AreaItemsPracticesAvg/Practicevs National
E 11.3K 86 131 +443.0% ▲
N 4,518 30 151 +522.3% ▲
RM 1,906 34 56 +131.8% ▲
IG 1,802 23 78 +223.6% ▲
B 1,174 36 33 +34.7% ▲
M 1,036 41 25 +4.5% ▲
NW 881 16 55 +127.7% ▲
SK 848 20 42 +75.2% ▲
CW 726 10 73 +200.0% ▲
PO 531 10 53 +119.4% ▲
TN 499 25 20 -17.4% ▼
LE 484 28 17 -28.5% ▼
PE 467 23 20 -16.1% ▼
BN 456 17 27 +10.7% ▲
S 441 16 28 +14.0% ▲
CR 367 8 46 +89.7% ▲
DN 367 12 31 +26.4% ▲
ME 328 15 22 -9.5% ▼
SW 324 9 36 +48.8% ▲
CV 296 20 15 -38.8% ▼

BNF Classification

Related drugs in this section

Data sourced from NHSBSA English Prescribing Dataset, CQC, and GP Patient Survey. Prescribing data does not indicate quality of care. Higher prescribing rates may reflect patient demographics. Always consult your GP for medical advice.